Cargando…
An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models
Huntington’s disease (HD) is a fatal, dominantly inherited neurodegenerative disorder caused by CAG trinucleotide expansion in exon 1 of the huntingtin (HTT) gene. Since the reduction of pathogenic mutant HTT messenger RNA is therapeutic, we developed a mutant allele-sensitive CAG(EX) RNA-targeting...
Autores principales: | Morelli, Kathryn H., Wu, Qian, Gosztyla, Maya L., Liu, Hongshuai, Yao, Minmin, Zhang, Chuangchuang, Chen, Jiaxu, Marina, Ryan J., Lee, Kari, Jones, Krysten L., Huang, Megan Y., Li, Allison, Smith-Geater, Charlene, Thompson, Leslie M., Duan, Wenzhen, Yeo, Gene W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829537/ https://www.ncbi.nlm.nih.gov/pubmed/36510111 http://dx.doi.org/10.1038/s41593-022-01207-1 |
Ejemplares similares
-
Abnormal Brain Development in Huntington’ Disease Is Recapitulated in the zQ175 Knock-In Mouse Model
por: Zhang, Chuangchuang, et al.
Publicado: (2020) -
CRISPR/Cas9 Mediated Therapeutic Approach in Huntington’s Disease
por: Alkanli, Suleyman Serdar, et al.
Publicado: (2022) -
Generation of New Isogenic Models of Huntington’s Disease Using CRISPR-Cas9 Technology
por: Dabrowska, Magdalena, et al.
Publicado: (2020) -
CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
por: Kolli, Nivya, et al.
Publicado: (2017) -
Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9
por: Shin, Jun Wan, et al.
Publicado: (2022)